Arginyl-Glutamine
Arginyl-Glutamine (Arg-Gln) is a dipeptide supplement shown to mitigate hyperoxic lung injury and reduce VEGF-driven retinal neovascularization in neonatal mouse models. Its protective effects in oxygen-induced injury models make it relevant for research in pulmonary and ophthalmological pathophysiology.
Product Specifications
Product Name Alternative
L-arginyl-L-glutamine, Arg-Gln
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
95.20% (May vary between batches)
Molecular Weight
302.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
031995 200 µL
APP (Y756) (APP, A4, AD1, Amyloid beta A4 protein, ABPP, APPI, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, N-APP, Soluble APP-alpha, Soluble APP-beta, C99, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, C83, P3 (42), P3 (40), C80, Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, Gamma-CTF (59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, Gamma-CTF (57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, Gamma-CTF (50), C31)
Sign In for Pricing
View Details 